About Us
Current Events
Past Events
Policy & Reports
Media Coverage
Contact Us

USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.

13th Annual BioPharma & Healthcare Summit, Thursday, May 9, 2019
Registration is closed
The Summit has reached full capacity. Registration is closed. There is no onsite registration.
Thanks for your overwhelming response. See you at 2020 summit!

BioPharma & Healthcare Summit - May 8, 2018

Chair and Emcee - Dr. Andrew Plump, Chief Medical & Scientific Officer, Takeda Pharmaceuticals

Time Topic
8-45 AM - 9-10 AM Registration and Networking
9-10 AM - 9-25 AM

Welcome address: Karun Rishi, President, USA-India Chamber of Commerce (USAIC)

Opening comments: Dr Andrew Plump, Chief Medical & Scientific Officer, Takeda Pharmaceuticals
9-25 AM - 10-15 AM

Panel Discussion: Industry-Academic Research Partnerships


  • Dr. Chas Bountra, Chief Scientist, Structural Genomics Consortium Oxford, University of Oxford
  • Dr. Jim Glasheen, Executive Vice Chancellor, University of Massachusetts Medical School
  • Dr. Jonathan Epstein, Executive Vice Dean & Chief Scientific Officer, Perelman School of Medicine, University of Pennsylvania
  • Dr. Nirmal Kumar Ganguly, President, Apollo Hospitals Educational & Research Foundation
  • Dr. Sridaran Natesan, Head - Strategic Initiatives & Scientific Relations, R&D, Sanofi North America

Juan Harrison, Vice President, Head of Strategic Academic Alliances, Takeda Pharmaceuticals

10-15 AM - 11-05 AM

Panel Discussion: Neuro Diseases                                                                                                          


  • Dr. Alfred Sandrock, Executive Vice President & Chief Medical Officer, Biogen
  • Dr. David Goldstein, Director, Institute for Genomic Medicine, Columbia University Medical Center
  • Dr. Maurizio Fava, Associate Dean, Clinical & Translational Research, Harvard Medical School
  • Dr. Meeta Chatterjee, Head, Business Strategy & Operations, Business Development & Licensing, Merck Research Labs
  • Dr. Steven Paul, President and Chief Executive Officer, Voyager Therapeutics

Dr. Steve Uden, Co-Founder, Rallybio

11-05 AM -11-35 AM Networking Break
11-35 AM - 12-25 PM

Panel Discussion: Oncology


  • Dr. Bruce Chabner, Director of Clinical Research, Mass General Hospital Cancer Center/Harvard Medical School
  • Dr. Kurt Stoeckli, President and Chief Scientific Officer, Glenmark Pharmaceuticals
  • Dr. Philip Rowlands, Head of the Oncology Therapeutic Area Unit, Takeda Pharmaceuticals
  • Dr. Victoria Richon, President & CEO, Ribon Therapeutics
  • Dr. Rakesh Jain, Director, E.L. Steele Laboratory of Tumor Biology,  Mass General Hospital Cancer Center/HMS

Dr. Raju Kucherlapati, Professor of Genetics, Harvard Medical School

12-25 PM - 1-00 PM

Fireside Chat:

  • Dr. Ansbert Gadicke, Founder & Managing Director, MPM Capital
  • Dr. Stelios Papadopoulos, Chairman, Biogen
  • Dr. Tsutomu Une, Senior Corporate Advisor, GCA Corporation

Dr. William Chin, Professor of Medicine, Emeritus, Harvard Medical School

1-00 PM - 2-40 PM

Luncheon Panel Discussion: Technology Platforms


  • Chris Benko, Co-Founder & CEO, Koneksa Health
  • Colin Hill, Chairman & CEO, GNS Healthcare
  • Dr. Peter Mueller, Chairman, BioXcel Therapeutics
  • Dr. Shahram Ebadollahi, Vice President, Innovations & Chief Scientific Officer, IBM Watson Health Group, IBM
  • Dr. Vijay Chandru, Chairman, Strand Life Sciences

Dr. Ajay Dhankhar, Senior Partner, McKinsey and Company

2-40 PM - 3-15 PM Networking & Tea Break
3-15 PM - 3-35 PM

BioPharma: An Extraordinary Disruption

Dr. Ajay Dhankhar, Senior Partner, McKinsey and Company
Sastry Chilukuri, Partner, McKinsey and Company

3-35 PM - 4-30 PM

Panel Discussion: Drug Discovery and Development


  • Dr Andrew Plump, Chief Medical and Scientific Officer, Takeda Pharmaceuticals
  • Dr. Mathai Mammen, Global Head of R&D, Janssen Pharmaceutical- Johnson & Johnson
  • Dr. Michael Ehlers, Executive Vice President and Head of Research & Development, Biogen

Dr. Martin Mackay, Co-Founder and CEO, Rallybio

4-30 PM - 5-05 PM

Fireside Chat:

  • Dr. George Daley, Dean, Harvard Medical School
  • Dr. Susan Hockfield, President Emerita & Professor of Neuroscience, Massachusetts Institute of Technology (MIT)

Dr Andrew Plump, Chief Medical and Scientific Officer, Takeda Pharmaceuticals

5-05 PM - 5-10 PM Closing Remarks
5-10 PM - 6-30 PM Cocktails & Networking Reception

*Luncheon Panel Discussion: Lunch will be served at the table at 1 PM. Panel will start at 1:50 PM
* Speaker and Timings subject to change

Please keep your cell phones in the silent mode

Pharmasia News   Biospectrum India Online

© 2007 - USA India Chamber of Commerce Home | About us | Agenda | | Policy | Events | Photo Gallery | Awards | Membership | Media Coverage | Internship/Volunteers | Legal | Contact us